The master regulator of the adaptive response to hypoxia is HIF-1. However, while some data show that HIF-1 can control more than 80% of the genes induced under hypoxia, other experiments clearly demonstrate that a part of the hypoxic response is independent of HIF-1. The goal of this study was to identify some of these HIF-1 independent factors and to investigate their functional role in the adaptation of tumor cells to hypoxia. We show that the cytoplasmic dynein intermediate chain 2 (DH IC-2), a component of an intracellular ATPase minus-end directed tubulin-based motile complex, was stabilized and posttranslationally modified under hypoxia in a HIF-1 independent way. We identified this modification as a phosphorylation by protein kinase C, which is inhibited under hypoxia. In parallel, the migration of HepG2 cells was enhanced under hypoxia. Cell migration was also increased, to the same extent, by the invalidation of DH IC-2 using siRNA. Taken together, these results suggest that under hypoxia, a specific modification of DH IC-2 may modulate its activity, and in turn promote cell migration. These results are important to better understand cancer development since they highlight a HIF-1 independent mechanism, which may be involved in metastasis.
Introduction
Oxidoreduction mechanisms are the most predominant way to provide energy supply to mammalian cells, which in turn allow cell survival and growth [1] . Hypoxia is characterized by a decrease in oxygen availability, and cells have to adapt in order to survive to this condition. The master regulator of this adaptive response to hypoxia is HIF-1 [2, 3] . This transcription factor is a member of the bHLH-PAS family and is composed of two subunits: HIF-1α and ARNT (aryl hydrocarbon receptor nuclear translocator) [4] . HIF-1α is the regulatory subunit of HIF-1 and is subjected to proteosomal degradation under normoxic conditions [5] . Under hypoxia, HIF-1α is stabilized and translocates into the nucleus where it associates with its constitutively expressed partner ARNT, which is also known to be involved in xenobiotic detoxification pathway [6] . HIF-1 can transactivate a variety of genes involved in multiple pathways such as glycolysis (enolase, aldolase, glucose transporter 1/3) [3] , angiogenesis [VEGF (vascular endothelial growth factor), VEGF-receptor 1] [7] , cell survival (Mcl-1) [8] and invasion (stromal cell derived factor 1-alpha, matrix metalloproteinase 1) [9] .
Within a tumor, hypoxia can occur at different states of its development [10, 11] . For example, when a tumor is growing, the cells close to the blood vessels are well oxygenated, but when the tumor mass expends, some cells are rejected to its periphery and they become being too far to receive oxygen by diffusion from adjacent capillaries [12] . Tumor cells also become hypoxic in case of blood flow arrest caused by any vascular problem like blood clot, by shunt or simply by the irregular blood flow observed in the immature tumor vascular system [13] .
Hypoxic conditions are important in cancer resistance to therapeutic treatments and are often associated with a poor patient prognosis [14] . This is due to a reduced accessibility of drugs to the hypoxic regions [15] , to multi-drug resistant channel overexpression in hypoxic tumor cells [16] and to protection from cell death by blockade of some apoptotic pathways [17] .
Consequently, several strategies are now developed aimed to invalidate the adaptive response of tumor cells to hypoxia [18] . Most of these approaches target the HIF-1 pathway or the VEGF receptor, and promising results have already been obtained [19] . However, while some data showed that HIF-1 could control until 80% of the genes induced under hypoxia [2] , other experiments clearly demonstrated that a part of the hypoxic response is independent of HIF-1 [20] [21] [22] [23] . In that way, and as tumor cells are well known to raise a high plasticity and to be able to escape from numerous regulatory mechanisms, it is important to better understand the HIF-1 independent actors of the adaptive response to hypoxia.
The goal of this study was to identify some of these HIF-1 independent factors and to investigate their functional role in the adaptation of tumor cells to hypoxia. For this purpose, we used the Biochimica et Biophysica Acta 1793 (2009) [1676] [1677] [1678] [1679] [1680] [1681] [1682] [1683] [1684] [1685] [1686] [1687] [1688] [1689] [1690] human hepatic cell line HepG2, a well-established hypoxia tumor cell model [8] , exposed to the chemical compound CoCl 2 , a well-known inducer of HIF-1 [24] or to true hypoxia.
In this report, we show that the cytoplasmic dynein intermediate chain 2 (DH IC-2), a component of an intracellular ATPase minus-end directed tubulin-based motile complex [25] , was stabilized and posttranslationally modified under hypoxia, in a HIF-1 independent way. DH IC-2 was phosphorylated by protein kinase C (PKC) under normoxia and was found to be de-phosphorylated under hypoxia. Dynein is a large multi-subunit protein principally composed of four components: the heavy chain (530 kDa), the intermediate chain (75 kDa), the light intermediate chain and the light chain (10-14 kDa) [26] . Dyneins are clustered in two groups: cytoplasmic and axonemal [27] . Cytoplasmic dyneins are involved in intracellular transport, mitosis, cell polarization and directed cell movement [28] . Axonemal dyneins are responsible for ciliary and flagellar beating [29] . We also showed that the migration of HepG2 cells was enhanced under hypoxia and, to the same extent, by the invalidation of DH IC-2 using siRNA. These results suggest that under hypoxia, a specific modification of DH IC-2 may modulate its activity, and in turn promote cell migration.
Materials and methods

Cell culture and stimulation
Murine hepatoma HepaC4 cells (kindly donated by Prof. Hankinson, UCLA) were cultured in Dulbecco's modified Eagle's medium high glucose-4000 mg/l (DHG) (Gibco, Paisley, UK) supplemented with Lglutamine (Sigma Aldrich, St. Louis, MO) containing 10% fetal calf serum (Gibco, Paisley, UK) at 37°C and 5% CO 2 . Cells were plated at 80% 1 day before the incubation under hypoxic or normoxic conditions.
Human hepatoma HepG2 cells (ATCC) were grown in Dulbecco's modified Eagle's medium low glucose-1000 mg/l (DMEM) (Gibco, Paisley, UK) supplemented with L-glutamine (Sigma, St. Louis, MO) containing 10% fetal calf serum (Gibco, Paisley, UK) at 37°C and 5% CO 2 . Cells were plated at 8 × 10 4 cells/ cm2 1 day before the incubation under hypoxic or normoxic conditions. Hypoxia incubations were performed in serum-free CO 2 -independent medium (Gibco, Paisley, UK) supplemented with 10 mM Lglutamine (Sigma Aldrich, St. Louis, MO) under 99% N 2 and 1% O 2 . Control normoxic cells were maintained under normal atmosphere (20% O 2 ). The oxygen concentration in the medium obtained in our experimental conditions is 10 mmHg.
Cycloheximide at 20 μM (CHX) (Sigma Aldrich, St. Louis, MO), MG132 at 20 μM (Biomol/Tebu-Bio Boechout, Belgium), calphostin C at 2 μM (El-198, Biomol/Tebu-Bio Boechout, Belgium), SB203580 at 20 μM (Alexis, Hausen, Switzerland), DRB at 100 μM (5,6-dichloro-1β-D-ribofuranosyl-benzimidazole, Biomol/Tebu-Bio Boechout, Belgium), PMA at 0.3 μM (phorbol-12-myristat-13-acetate, Sigma Aldrich, St. Louis, MO) and CoCl 2 at 150 μM (Sigma Aldrich, St. Louis, MO) incubations were performed in serum-free CO 2 -independent medium (Gibco, Paisley, UK) supplemented with 10 mM Lglutamine (Sigma Aldrich, St. Louis, MO). All supplemented media were filtered on 0.22 μm porous membrane.
2D DIGE analyses
Sample preparation
After elimination of the medium, cells were collected in 1 ml of pre-cooled PBS, transferred into microtubes and centrifuged 4 min at 1000 rpm at 4°C. The pellets were lysed with the DIGE Labeling (DLA) buffer (CHAPS 4%, urea 7 M, thiourea 2 M, Tris 30 mM, pH 8.5) and clarified by centrifugation at 13,000 rpm for 5 min at 4°C.
Protein labeling
Protein concentrations were determined in triplicates by the Bradford method (Bio-Rad, München, Germany) and extracts were diluted to reach a final concentration of 5-10 μg/μl. The pH of the samples was adjusted to 8.5. Each sample (25 μg) was minimally labeled with the CyDyes DIGE (Amersham GE Healthcare, Uppsala, Sweden) during 30 min in the dark (200 pmol of amine-reactive cyanine dyes, Cy3 or Cy5) at 4°C following the manufacturer's instructions. An internal standard, obtained after pooling an equal amount of the six different samples, was labeled with Cy2. Labeling was stopped by incubating the mixture 10 min with 1 μl of 10 mM lysine (Sigma Aldrich, St. Louis, MO). Each gel was then loaded with 25 μg of mixed labeled samples (normoxia and normoxia + CoCl 2 , or normoxia and hypoxia) and 25 μg of the internal standard. The different mixes of proteins were diluted twice (CHAPS 4%, urea 7 M, thiourea 2 M, Tris 30 mM, DTT 30 mM, IPG buffer 4-7 (v/v) 1%) (Amersham GE Healthcare, Uppsala, Sweden) and reduced 20 min in the dark at room temperature before clarification by centrifugation at 13,000 rpm during 10 min.
Two-dimensional differential in-gel electrophoresis
The first dimension was performed with Immobiline DryStrips (IPG strip continuous pH 4-7 gradient 24 cm; Amersham GE Healthcare, Uppsala, Sweden). IPG strips were rehydrated in an Immobiline DryStrip reswelling tray (Amersham GE Healthcare, Uppsala, Sweden) for 24 h at RT with 450 μl of rehydration buffer (CHAPS 4%, urea 7 M, thiourea 2 M, Tris 30 mM, DTT 30 mM, IPG buffer 4-7 (v/v) 0.5%) and covered with 2.5 ml DryStrip oil. Samples were loaded in a cupule at the more acidic part of the IPG strips. Isoelectric focusing (IEF) was run on an IPGphor isoelectric focusing system (Amersham GE Healthcare, Uppsala, Sweden) with the following parameters: 300 V for 3 h, gradient step of 1000 V for 8 h, gradient step of 8000 V for 3 h and 8000 V for 65,000 V/h at 20°C with a maximum current setting of 50 μA/strip. IPG strips were then washed with distillated water, and incubated subsequently for 15 min with an equilibration buffer [Tris-HCl 50 mM (pH 8.8), urea 6 M, glycerol (v/v) 30%, SDS (w/v) 2%] supplemented with DTT 10 mg/ml or iodoacetamide 25 mg/ml, respectively. The IPG strips were then washed with running buffer [Tris-HCl 50 mM (pH 8.5), glycine 384 mM, SDS 0.2%] twice concentrated and sealed with agarose 0.5% (containing bromophenol blue) on the top of a 10% SDS-PAGE pre-poured between low fluorescent glass plates using an Ettan-DALT caster (Amersham GE Healthcare, Uppsala, Sweden). Twice concentrated buffer and normal running buffer were added at the top and the bottom of the gels, respectively. Electrophoresis was performed overnight (16 h) at 14°C with 1 W/gel in the EttanDalt II system (Amersham GE Healthcare, Uppsala, Sweden). The three gels from a same experiment were run at the same time.
Image acquisition and statistical analysis
In order to observe cyanin-labeled proteins, gels were scanned in fluorescence with Typhoon 9400 imager (Amersham GE Healthcare, Uppsala, Sweden) at a resolution of 100 μm. Cy2 images were obtained from a 488 nm excitation laser coupled to a 520 nm emission filter. Cy3 images were obtained from a 532 nm excitation laser coupled to a 580 nm emission filter. Cy5 images were obtained from a 633 nm excitation laser coupled to a 670 nm emission filter. A total of nine gel images was generated for each comparative experiment and analyzed using DeCyder Differential Analysis Software v6.0 (Amersham GE Healthcare, Uppsala, Sweden) for spot detection, matching, quantitation and statistical analysis. First, a differential in-gel analysis (DIA) was applied on each gel to eliminate gel-to-gel variance by matching and normalizing every spot gel with the corresponding internal standard. Second, a biological variation analysis (BVA) software, using student's t test (p b 0.05), was run to detect statistical differential protein expression between the control and treated groups. Depending on the experiment, spots of interest were defined as spots with at least 1.3-or 1.5-fold change in abundance after normalization.
Sample recovering
A preparative 2D gel was performed with 300 μg of unlabeled proteins obtained by pooling the same amount of proteins from the six samples used for the analytical gels. The protocol remained unchanged as for analytical gels except that the sample was loaded in two times for the first dimension in order to decrease protein precipitation; for the second dimension, one of the low fluorescent glass plates was pre-treated with bind-silane (Amersham GE Healthcare, Uppsala, Sweden). At the end, the plate without bindsilane was removed and the gel was incubated in a fixating solution (ethanol 30%, acetic acid 10%) for 5 h. Gels were then washed three times for 30 min with distilled water before overnight protein staining with 1 l of ethanol 20% supplemented with 7 μl of 20 mM Ruthenium II solution [Ruthenium II tris (bathophenantroline disulfonate)]. Gels were then washed twice with distilled water (Milli-Q system, Millipore, Bedford, MA) for 10 min. Gels were scanned with Typhoon 9400 imager (Amersham GE Healthcare, Uppsala, Sweden) using a 532 nm excitation laser coupled to a 610 nm emission filter. After matching the preparative gel picture to the master analytical gel image, spots of interest were localized on the preparative gel and picked with an automated Ettan Spot Picker (Amersham GE Healthcare, Uppsala, Sweden) following the manufacturer's instructions. Spots were transferred in a 96-well plates and kept frozen at −20°C until protein digestion.
Protein extraction and digestion
Gel fragments were washed twice with distilled water (Milli-Q system, Millipore, Bedford, MA) and once with acetonitril (ACN) 100% at 900 rpm and 21°C for 10 min. Pellets were then dried at 56°C, reduced with DTT 10 mM (Sigma Aldrich, St. Louis, MO) in NH 4 HCO 3 100 mM during 45 min at 900 rpm and 56°C, before alkylation through incubation in iodoacetamide 55 mM in NH 4 HCO 3 100 mM during 30 min in the dark. Gel fragments were washed with distilled water (Milli-Q system, Millipore, Bedford, MA), twice with ACN 100% for 5 min at 900 rpm, once with NH 4 HCO 3 100 mM at 900 rpm for 5 min and once with ACN 100% at 900 rpm for 10 min. Pellets were dried at 37°C during 20 min. Proteins were first digested on ice with trypsin 12.5 ng/μl (Promega, Madison) in 50 mM NH 4 CO 3 for 45 min, and then overnight at 37°C. Peptides were extracted with 10 μl acid formic 5% and the collected supernatants were kept frozen at -20°C until mass spectrometry analysis.
Protein identification
Digested peptides were first separated on a nano C18 column (Atlatis, 75 μM, 150 mm, 3 μm NanoEase column; Waters, Milford) and then identified by Nano-LC-QTOF-MSMS. The mass spectrum of peptide fragments was obtained through the use of a CapLC in tandem with a Q-time-of-flight 2 (Q-TOF2) (Waters, Milford) coupled to the MassLynx 4.0 software (Waters, Milford).
Some proteins were also identified on the basis of their "peptide mass fingerprint" obtained with a matrix-assisted laser desorption/ ionization MX (Maldi) (Waters, Milford). Peptide mass maps were acquired in the reflectron mode with delayed extraction. Mass spectra were internally calibrated with trypsin autolysis peaks.
Full-length proteins were identified with Mascot software (version 2.0) (Matrix Sciences, London, UK) by sequence homology research against human or murine protein databases.
Western blot
After elimination of the medium, cells were collected in 1 ml of pre-cooled PBS and transferred into microtubes. Microtubes were centrifuged 4 min at 1000 rpm at 4°C. Supernatants were removed and pellets were lysed with the extraction buffer [Tris 80 mM, pH 7.5 (Merck, Darmstadt, Germany), KCl 300 mM (Merck, Darmstadt, Germany), EDTA 2 mM (Merck, Darmstadt, Germany), Triton X-100 1% (v/v) (Sigma, St. Louis, MO), containing a protease inhibitor mixture (≪Complete≫ from Roche Molecular Biochemicals, 1 tablet in 2 ml H 2 O, added at a 1:25 dilution) and phosphatase inhibitors (NaVO 3 25 mM, PNPP 250 mM, β-glycerophosphate 250 mM and NaF 125 mM, at a 1:25 dilution)]. Microtubes were then centrifuged 4 min at 13,000 rpm at 4°C. Supernatants were collected and stored at −80°C . Protein concentrations were determined according to the Bradford method (Bio-Rad, München, Germany). Equal amounts of protein (20-40 μg) were then separated by SDS-PAGE on 10% acrylamide gel and transferred to a polyvinyldiene difluoride membrane (Amersham Biosciences, Uppsala, Sweden). Membranes were blocked with Tris buffer saline supplemented with 0.1% (v/v) Tween and 2% (w/v) dried milk (ECL detection kit, Amersham GE Healthcare, Uppsala, Sweden), and probed with the following antibodies: anti-HIF-1α antibodies (BD Transduction Laboratories; diluted 1:2000), secondary antibody anti-mouse horseradish peroxidase-conjugated (Amersham GE Healthcare, Uppsala, Sweden; diluted 1:300,000), anti-α-tubulin antibodies (Sigma, St. Louis, MO; diluted 1:50,000), secondary antibody anti-mouse horseradish peroxidase-conjugated (Amersham GE Healthcare, Uppsala, Sweden; diluted 1:300,000), anti-DH IC-2 intermediate chain antibodies (Abcam #ab6304, clone 70.1; diluted 1:50,000), secondary antibody anti-mouse horseradish peroxidaseconjugated (Amersham GE Healthcare, Uppsala, Sweden; diluted 1:300,000), anti-p53 antibodies (Upstate; diluted 1:5000), and secondary antibody anti-mouse horseradish peroxidase-conjugated (Amersham GE Healthcare, Uppsala, Sweden; diluted 1:300,000). Proteins were detected by chemoluminescence (ECL detection kit, Amersham GE Healthcare, Uppsala, Sweden) using a Fujifilm FPM-100A (Fujifilm, Düsseldorf, Germany). Films were scanned with the Image Master Labscan V2003.01 Software (Amersham GE Healthcare, Uppsala, Sweden) and semi-quantitated with the ImageQuant TotalLab V2,3.03 software (Amersham GE Healthcare, Uppsala, Sweden).
2D-blot
Cells were collected and lysed and 100 μg of each sample were prepared as for 2D preparative gels. First dimension was performed with Immobiline DryStrips (IPG strip continuous pH 4-7 gradient, 18 cm; Amersham GE Healthcare, Uppsala, Sweden) pre-rehydrated during 24 h at RT with 350 μl of rehydration buffer (CHAPS 4%, urea 7 M, thiourea 2 M, Tris 30 mM, DTT 30 mM, IPG buffer 4-7 (v/v) 0.5%). Samples were loaded as for 2D gels, and ran with the following parameters: 300 V for 3 h, gradient step of 1000 V for 8 h, gradient step of 8000 V for 3 h and 8000 V for 25,000 V/h at 20°C with a maximum current setting of 50 μA/strip [IPGphor isoelectric focusing system, Amersham GE Healthcare, Uppsala, Sweden]. IPG strips were then washed, equilibrated and sealed with agarose 0.5% (containing bromophenol blue) on the top of a 10% SDS-PAGE as for 2D gels. After protein separation, samples were transferred to a polyvinyldiene difluoride membrane (Amersham Biosciences, Uppsala, Sweden), blocked with phosphate saline buffer supplemented with 0.1% (v/v) Tween and 2% (w/v) dried milk (ECL detection kit, Amersham GE Healthcare, Uppsala, Sweden) and probed as described for Western blot. The three gels of a same experiment were run at the same time.
Immunoprecipitation
HepG2 cells were seeded at 80,000/cm2 in DMEM + 10% FBS and grown for 24 h before starting the experiments. After the incubation, cells were lysed in 1 ml IP lysis buffer [ ]. An aliquot of 50 μl was kept for assessing the protein level of DH IC-2 in the cell extracts. Lysates were incubated 2 h at 4°C with 2.5 μg of anti-DH IC-2 IgG, then 2 h at 4°C with 50 μl proteinA/G coated beads (BD bioscience). The beads were washed three times with 800 μl of the IP lysis buffer, after which DH IC-2 was recovered by incubating the beads in Laemmli buffer for 10 min at 100°C. Samples were resolved on 10% SDS-PAGE and transferred on polyvinyldiene difluoride membrane. Proteins were detected with anti-DH IC-2 or pan-serine/threonine specific IgG (#44-006, Upstate, Lake Placid).
PKC kinase activity assay
HepG2 cells were seeded at 80,000/cm2 in DMEM + 10% FBS and grown for 24 h before starting the experiments. After the incubation, the medium was removed and replaced with 1 ml of fresh lysis buffer and was added per T25 flask and the flasks were put on ice. After 10-min incubation period, cells were scraped using a cell scraper and cell lysates were collected in a pre-chilled 1.5 ml microtube kept on ice. Microtubes were centrifuged at 13,000 × g for 15 min at 4°C. Clear supernatant was transferred to a prechilled 1.5 ml microtube and protein concentration was determined using Bradford method. The assay was performed immediately after cell lysis using a PKC Kinase Activity Assay Kit (Non-Radioactive) (Assay Designs, Ann Arbor) with 20 μg of fresh lysate proteins for each condition.
Total RNA extraction and reverse transcription
After the incubation, the medium was removed and total RNA extraction was performed using RNAgents kit according to the manufacturer's instructions (RNAgents, Total RNA Isolation System, Promega, Madison). For each condition, 2 μg of total RNA were mixed with 2 μl oligo (dT) (500 ng/μl) (Gibco, Paisley, UK). The volume was then brought up to 9 μl with nuclease-free water (Promega, Madison). This mix was first incubated for 10 min at 70°C and then on ice for 5 min. Reaction mix [9 μl; 4 μl Buffer RT 5X (Promega, Madison), 2 μl DTT 0.1 M (Promega, Madison), 1 μl RNAsin (40 U/μl) (Promega, Madison), 2 μl dNTP mix (Eurogentec, Seraing, Belgium)] was added and the samples were left for 5 min at room temperature. After addition of 1.5 μl SuperScriptRII (200 U/μl) (Invitrogen, Carlsbad), the samples were incubated for 90 min at 42°C and then for 15 min at 70°C. Finally, 1 μl of Ribonuclease H (2 U/μl) (Gibco, Paisley, UK) was incubated with the samples for 20 min at 37°C before being stored at −20°C. Sequences of the primers were determined using Primer Express 1.5 software (Applied Biosystems, Foster City): DH IC-2, 5′-AACACAAAATGCTCACAA-TCTGATTAG-3′ (forward) and 5′-TGCTATCCTGTGGATGGGAAA-3′ (reverse); aldolase, 5′-TGCGCAGGAGGAGTATGTCA-3′ (forward) and 5′-AGGCGTGGTTAGAGACGAAGAG-3′ (reverse); Rpl13, 5′-GC CTACA AGAAAG TTTGC CTATCTG-3 ′ ( f o r w a r d ) an d 5 ′ -TGAGCTGTTTCTTCTTCCGGTAGT-3′ (reverse). cDNAs and primer concentrations were experimentally determined to allow PCRs to remain in the exponential zone of amplification, and the specificity of the PCR was checked by carrying out a dissociation curve with a gradient from 60°C to 95°C. cDNAs (5 μl) were added to SYBR Green Master Mix PCR [2.5 μl distilled water, 1.7 μl of reverse primer at 9 μM, 1.7 μl of forward primer at 9 μM, 12.5 μl of SYBR green] and PCRs were performed in 7900 HT Fast Real Time PCR System (Applied Biosystems, The Netherlands) using SDS 2.2.1 Software (Applied Biosystems, The Netherlands). Thermal cycling conditions were as follows: 2 min at 50°C, 10 min at 95°C, 40 cycles of 30 s at 95°C, 1 min at 57°C and 30 s at 72°C. Rpl13 amplification was used as a standard to normalized differences between samples, and fold induction was estimated with the classical "ΔΔC T method" [30] . PCR efficiency was higher than 90% for all genes.
Immunofluorescence
HepG2 cells were seeded at 25,000/ cm2 in DMEM + 10% FBS and grown on glass cover slide for 24 h before starting the experiments. After the incubation, the medium was removed, and cells were fixed for 10 min with PBS containing 4% (w/v) paraformaldehyde (Merck, Darmstadt, Germany). Fixed cells were washed three times with PBS and permeabilized with PBS-Triton X-100 1% (w/v) (Sigma, St. Louis, MO) during 4 min. After three washing steps with PBS containing 2% (w/v) bovine serum albumin (BSA) (PAA Laboratories), cells were incubated during 2 h under wet atmosphere at room temperature with anti-DH IC-2 intermediate chain antibodies [Abcam #ab6304, clone 70.1; diluted 1:100 in PBS + 2% (w/v) BSA]. Cells were then washed three times with PBS + 2% (w/v) BSA, and the secondary antibodies conjugated to Alexa fluorochrome 488 [Molecular Probes; diluted 1:1000 in PBS + 2% (w/v) BSA] were added under wet atmosphere at room temperature for 1 h. The cells were then washed three times with PBS. Nuclei were labeled with Topro-3 [Molecular Probes; diluted 1:80 in PBS + RNase 2 mg/ml (ICN)] during 30 min. Finally, the cells were mounted in mowiol (Sigma, St. Louis, MO). Observations were performed with a confocal microscope using a constant photomultiplier (Leica, Groot Bijgaarden, Belgium).
Cell viability assay
HepG2 cells were seeded at a density of 12 × 10 3 /cm2 in DMEM + 10% FBS and grown on 24 h before starting the experiments. After the incubation, cell viability was evaluated by 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide reduction assay (MTT) (Sigma, St. Louis, MO) [31] . MTT solution was added volume-to-volume for 2 h at 37°C under 5% CO 2 , and then discarded before overnight incubation in lysis buffer [20% SDS (MP Biomedicals, Eschwege, Germany), 33.3% N,N-dimethyl-formamide (Merck, Darmstadt, Germany), pH 4.7] under shaking (100 rpm) at 37°C in the dark. The OD values were recorded at 570 nm (plate reader Ultramark Microplate Imaging System, Bio-Rad, München, Germany).
Migration assay
HepG2 cells were plated (100,000/300 μl/well) in Boyden chambers, on the top of 8 μm pore polycarbonate membrane (Transwell, Costar, Corning, NY) in serum-free CO 2 -independent medium (Gibco, Paisley, UK) supplemented with 10 mM L-glutamine (Sigma, St. Louis, MO). These chambers were maintained in 24-wells plates and 600 μl/well of CO 2 -independent medium (Gibco, Paisley, UK) supplemented with 10 mM L-glutamine (Sigma, St. Louis, MO) and 10% FBS were placed at the bottom of wells as a chemotaxis inducer. After 24-h incubation, the cells having migrated on the other side of the porous membrane were stained with crystal violet [crystal violet 4.8 mM (Janssen, Geel, Belgium), ethanol 2%] as follows: Transwell inserts were first washed three times in PBS, fixed 45 s with methanol pre-cooled to −20°C, washed three times with distilled water, incubated 45 s with crystal violet solution and washed three times with distilled water. The top of the porous membranes was then cleaned of cells twice with a cotton swab, cut with a scalpel blade and mounted with Glycergel (Dako, Denmark). Cover slides were maintained under weight overnight at room temperature to avoid air bubbles. Observations were performed with DIALUX 20EB photonic microscope (Leica, Groot Bijgaarden, Belgium) coupled with a DC100 camera (Leica, Groot Bijgaarden, Belgium), using DC100PPC software. Pictures were taken at the same swelling, contrast and luminosity.
siRNA transfection
In order to invalidate HIF-1α or DH IC-2 expression, siGENOME SMARTpool siRNA reagents M-0044018-02 and M-012574-00 were, respectively, ordered from Dharmacon (Erembodegem, Belgium). Non-targeting oligoribonucleotides D-00120-01-20 (Dharmacon, Erembodegem, Belgium) was used as negative control. One day before transfection, HepG2 cells were plated at 40 × 10 3 /cm2 and grown in DMEM + 10% FBS. Cells were transfected according to the manufacturer's instructions (Dharmacon, Erembodegem, Belgium) for 24 h with siRNA at 50 nM in DMEM medium using Dharmafect 1 transfection reagent. Cells were seeded 24 h after transfection for the different assays.
In silico analysis tools
The in silico analysis tools are available online: http://www.cbs. dtu.dk/services/NetPhos/, http://www.ba.itb.cnr.it/BIG/UTRScan/, http://www.expasy.org/tools/ -ptm, http://www.matrixscience. com/. Table 2 .
Statistical analysis
One way analysis of variance (ANOVA) with post-hoc pairwise comparison using Holm-Sidak method was performed using Sigma-Stat.3 software.
Results
2D-DIGE analysis, experimental procedure and mass spectrometry
In order to identify HIF-1 independent proteins involved in the adaptive response to hypoxia, we used the murine hepatoma cell line HepaC4, which lacks ARNT, and hence, does not harbor a functional HIF-1. Cells were first incubated during 16 h under normoxia or hypoxia. After lysis, proteins were labeled with different dyes to perform 2D-DIGE approach and the gels were analyzed by the DeCyder software [32] . We decided to focus on proteins that had their relative abundance statistically modified at least by 50% under hypoxia in comparison to normoxia (p = 0.05).
A total of 21 hypoxia-responsive proteins were identified by mass spectrometry ( Table 1 ). Most of them were clustered into cytoskeleton or associated to cytoskeleton proteins (like vimentin, cortactin, DH IC-2 and lamin). We then tried to confirm these variations using Western blot analyses. However, no correlation between the apparent modification of abundance observed in 2D-DIGE and the abundance of the proteins was observed. Real-time PCR, to assay the mRNA level, and immunofluorescence, to evidence changes in abundance and in subcellular localization, did not neither reveal any variation (data not shown).
In order to circumvent this problem, we decided to use the same kind of approach using a closely related human hepatoma cell line, the HepG2 cells. We decided to compare the protein profile of cells incubated under hypoxia to the one of cells incubated in the presence of CoCl 2 under normoxia. Hypoxia allowed us to identify HIF-1 dependent and independent hypoxia-responsive proteins while CoCl 2 only highlighted the HIF-1 dependent ones. We next removed the common proteins of both experiments and generated a list of HIF-1 independent hypoxia-responsive proteins. To optimize our chances to identify proteins common with the previous experiment, we focused our attention on proteins that had their relative abundance changed at least by 30% under hypoxia. Normoxia was used as the control.
First, to confirm that HepG2 cells are responsive to CoCl 2 , we checked the stabilization of HIF-1α under normoxia in the presence of CoCl 2 or under hypoxia after 16 h incubation (data not shown). Hypoxia and CoCl 2 did indeed lead to an increase in HIF-1α protein level. Second, we carried out 2D-DIGE approach where HepG2 cells were incubated under normoxia, normoxia with CoCl 2 or hypoxia for 16 h. Fig. 1 illustrates the protein spots resolved by two-dimensional electrophoresis for the three experimental conditions used here. After comparison of the hypoxic and CoCl 2 -induced protein profiles, common spots were removed and we generated a list of 77 spots responsive to hypoxia in a HIF-1 independent manner. Out of these spots, 63 proteins were identified by mass spectrometry and clustered into different groups: cytoskeleton or cytoskeleton-associated proteins (like coronin-1B, Factin capping protein alpha-2 subunit and DH IC-2), proteins involved in translation process (like elongation factor 2, HNRPK, HNRPC and aconitase), stress proteins, kinases and so on ( Table 2) .
We decided to focus on cytoskeleton proteins for two major reasons. First, some of them were already identified in the preliminary experiment using HepaC4, like cortactin and DH IC-2. Second, these cytoskeleton proteins may be involved in the migration process, which is known to be enhanced under hypoxic conditions [33] .
Increase in DH IC-2 protein level under hypoxia
In order to check whether the abundance of the different cytoskeleton proteins identified by mass spectrometry are indeed increased under hypoxia, HepG2 cells were incubated 16 h under hypoxia or normoxia. Then, cells were lysed and total cell extract proteins were loaded onto 10% SDS-PAGE. The abundance of five cytoskeleton proteins identified in the previous study was monitored by Western blot. The protein level of DH IC-2 was found to be increased under hypoxia as shown in Fig. 2A . The hypoxia-induced increase in DH IC-2 abundance was also confirmed by immunofluorescence ( Fig. 2B ), but no change in subcellular localization was observed. A time curve was also performed and the results show that DH IC-2 abundance began to increase already after 4 h of incubation under hypoxic conditions (Fig. 2C ). All these experiments were performed at least three times (data not shown).
DH IC-2 mRNA level in HepG2 cells under hypoxia
To determine whether the DH IC-2 up-regulation observed under hypoxia is dependent on a transcriptional regulation, DH IC-2 mRNA level was quantitated by real-time PCR. HepG2 cells were incubated under hypoxia or normoxia in the presence or not of CoCl 2 . Total mRNA was extracted and retrotranscripted into cDNA. Fig. 3 shows that neither hypoxia nor CoCl 2 did change the mRNA level of DH IC-2. On the other hand, both conditions did increase the mRNA level of aldolase, a well-known HIF-1 target gene (Fig. 3) . These results indicate that it is probably not through enhanced transcription that the protein level of DH IC-2 is increased under hypoxic conditions.
DH IC-2 stabilization under hypoxia
In order to discriminate between protein stabilization and enhanced translation to explain the increased protein DH IC-2 expression under hypoxia, a time course analysis using cycloheximide 10 μM (CHX), a well-known inhibitor of mammalian cell translation [34] , was performed under normoxia or hypoxia. As shown in Fig. 4A , when HepG2 cells were treated with CHX under hypoxia, the total amount of DH IC-2 did not diminish regardless of the incubation duration. There was rather an increase in DH IC-2 protein abundance. However, under normoxia, the level of DH IC-2 slightly decreased according to the duration of the time course experiment. These results suggest that, under hypoxia, the pool of DH IC-2 was stabilized, and this contributed to the accumulation of the protein. This effect may be due to an inhibition of the DH IC-2 degradation pathway under hypoxia. As proteasome is one of the major proteolytic systems of mammalian cells [35] , we checked whether it could be involved in DH IC-2 degradation. To this aim, we used the proteasome inhibitor MG132 [36] at 40 μM under normoxia and the protein level of DH IC-2 was monitored by Western blot. As shown in Fig. 4B , DH IC-2 level was not modified under normoxia regardless of the incubating conditions, suggesting that another degradation pathway may be involved in DH IC-2 turn over. p53 was used as a positive control of proteasome inhibition. Its abundance indeed increased in the presence of MG132 (Fig. 4B ).
DH IC-2 post-translational modification under hypoxia
Since changes in 2D gel spots may be due to changes in expression but also in post-translational modification, we checked if DH IC-2 would also be post-translationally modified under hypoxia. 2D-blot analyses were performed on proteins from HepG2 cells incubated under the three different conditions. As shown in Fig. 5 , DH IC-2 was detected as two distinct spots under normoxia and after the incubation in the presence of CoCl 2 . However, under hypoxia, only one spot remained. These results suggest that DH IC-2 is modified under hypoxia. Similar results were obtained for other cytoskeleton proteins like tubulin, cortactin and coronin-1B (data not shown). The DH IC-2 shift observed by 2D-blot under hypoxia, from the more acidic form to the less one, may correspond to a loss of negative (continued on next page) charges or a gain of positive ones. It may reflect, for example, a loss of phosphorylation or of acetylation of this protein under hypoxia. In silico research pointed out several potential phosphorylation sites in the DH IC-2 protein sequence (data not shown). The intensity of the spot detected under hypoxia by 2D-blot analysis should be more than the sum of the two spots detected under normoxia. It is however possible that the affinity of the antibody for the unphosphorylated form would not be the same as its affinity for the phosphorylated form, that would explain our results.
In order to confirm that the change in the phosphorylation state of DH IC-2 was independent of HIF-1, HIF-1α was invalidated using siRNA. Fig. 6 shows that while HIF-1α protein abundance was markedly decreased, HIF-1α invalidation did not influence the effect of hypoxia on the modification of DH IC-2 observed on 2D-blot.
In order to identify the putative kinase responsible for the phosphorylation of DH IC-2 under normoxia, we performed immunoprecipitation studies. Cells were first treated with inhibitors of different kinases (calphostin C for PKC, DRB for CK2 and SB203580 for p38) under normoxic conditions or incubated in the presence of CoCl 2 or under hypoxia and were then lysed. DH IC-2 was immunoprecipitated from the lysates, run onto a SDS-PAGE gel and revealed with an anti-phosphorylated pan-serine-threonine antibody. The results show that DH IC-2 was indeed phosphorylated under normoxic conditions, CoCl 2 did not influence it while hypoxia strongly inhibited this phosphorylation (Fig. 7A) . Moreover, under normoxia, the phosphorylation was inhibited in the presence of calphostin C, a PKC inhibitor, but not when CK2, p38 (Fig. 7A ) or ERK (data not shown) was inhibited. In order to confirm these results, 2D-blot analyses were performed on proteins from HepG2 cells incubated under normoxia with or without calphostin C. As shown in Fig. 7B , calphostin C markedly decreased the abundance of the more acidic spot while in parallel it increased the abundance of the less acidic one, which is similar to what was observed under hypoxia (see Fig. 5 ). All together, these results suggest that DH IC-2 is phosphorylated by PKC under normoxia and that hypoxia inhibited this post-translational modification.
In order to support this hypothesis, actual PKC activity was assayed. Results from Fig. 7C show that hypoxia significantly decreased PKC activity, while CoCl 2 had no effect. PMA, used as a positive control, strongly increased PKC activity. It must be noted that Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis.
HepG2 cells were incubated 16 h under hypoxia or normoxia and CoCl 2 . Normoxia was used as the control. Hypoxia-responsive HIF-1 independent proteins were selected and then identified by mass spectrometry using a Nano-LC-QTOF-MSMS coupled to the the effect of calphostin C on PKC activity could not be measured because it interfered with the measure of the optical density. These data suggest that hypoxia may inhibit PKC activity after 16 h of incubation.
DH IC-2 and migration
As DH IC-2 and other cytoskeleton proteins are modified under hypoxia, we decided to investigate the possibility that these modifications may affect cellular migration. For this purpose, DH IC-2 was invalidated in HepG2 cells by the use of siRNA. As a first step, we checked, in a time course experiment, that expression of DH IC-2 was knocked-down after cell transfection in the presence of the siRNA. As shown in Fig. 8 , total invalidation of DH IC-2 was achieved 24 h posttransfection and remained stable at least until 72 h post-transfection.
We decided to perform the experiments between 24 and 48 h posttransfection, according to the type of the assay. In order to observe the impact of DH IC-2 invalidation on cell migration, transfected HepG2 cells were seeded on the top of porous membrane of Boyden-like chambers. The chambers were then incubated either under normoxia or hypoxia for 24 h. As shown in Fig. 9 , HepG2 cells showed a higher migration when incubated under hypoxia. This result is in accordance with different in vitro and in vivo data from the literature, which show an increase in metastatic potential in hypoxic cancers [9, 37] . We also observed, that under normoxia, HepG2 cells transfected with DH IC-2 targeting siRNA had a much more potent capacity to migrate through the porous membrane than control cells. Under hypoxia, this difference was attenuated. Under hypoxia, the total abundance of DH IC-2 is increased and the protein is no longer phosphorylated. In these conditions, HepG2 migration is enhanced. Two hypotheses can thus be put forward: (i) it is the abundance of DH IC-2 that regulates migration or (ii) that is the fact that DH IC-2 is phosphorylated or not. Since when DH IC-2 expression is lowered (by the use of siRNA), migration is also enhanced, we concluded that it is not its abundance that regulates migration (otherwise we should have observed an inhibition). We thus proposed that the phosphorylated form inhibits migration, while the unphosphorylated one favors migration: hypoxia, by inhibiting PKC activity and, hence, DH IC-2 phosphorylation would thus enhance cell migration. In order to confirm this hypothesis, we used calphostin C, a specific PKC inhibitor: under normoxia, PKC inhibition also resulted in an enhanced migration as hypoxia did (Fig. 10A and B) . The effect of calphostin C was similar to the one of hypoxia, i.e., an increase in cell migration but the extent of the effect was lower. This may be due to the fact that migration may be regulated by several pathways under hypoxia, one of them being PKC which is inhibited by calphostin C but the others would not be inhibited. In conclusion, hypoxia enhances migration at least in part by inhibiting DH IC-2 phosphorylation. These results suggest that DH IC-2 may be implicated in regulating the migration process, with a negative impact on migration in well-oxygenated conditions.
In parallel with the migration experiments, transfected HepG2 cells were seeded to perform proliferation assays, and incubated under normoxia or hypoxia during 24 h. Cell density was estimated by the MTT method. As shown in Fig. 11 , invalidation of DH IC-2 did not change HepG2 cell proliferation rate. Taken together, these results showed that cell migration is enhanced by hypoxia and, to the same extent, by DH IC-2 invalidation in a ce:paraproliferation-independent way.
Discussion
Cancer represents one of the major causes of mortality in developed countries. Today, tumor hypoxia is a hot spot in cancer research and its impact on cancer development and patient outcome is well described. As hypoxia is more often correlated with a poor prognosis for the patient [38] , adaptive responses to hypoxia are intensively investigated. HIF-1 controls the majority of the genes induced by hypoxia [2] and most of the studies that try to impair cancer cell adaptation to hypoxia are focused on the HIF pathway [19] . However, some data clearly show that other factors may also participate to this adaptation, through a transcriptional effect or in other ways like protein interaction or post-translational modification [20] [21] [22] [23] . Indeed, overexpression of a constitutive active form of HIF-1 does not recapitulate all the genes induced by hypoxia [20] , and the invalidation of HIF-1 does not suppress the apoptosis protection observed under hypoxia, indicating that HIF-1 independent processes are involved [21] . In order to investigate these processes, we decided to identify proteins that participate to cellular adaptation to hypoxia in a HIF-1 independent way. We used the murine cell line HepaC4, which lacks the ARNT subunit of HIF-1 [39] . In that way, HepaC4 cells do not have a functional HIF-1 and can not transactivate HIF-1 target genes [40] . 2D-DIGE analyses were performed in order to identify hypoxia-responsive HIF-1 independent proteins, but no correlation was observed between the apparent overexpression pointed out in these analytical analyses and the mRNA or protein level of the putative candidates. These discrepancies between 2D-DIGE, real-time PCR and Western blot results are probably due to the fact that 2D-DIGE highlights post-translational modifications in addition to changes in overall expression. In order to increase the probability to identify some hypoxia-responsive HIF-1 independent proteins, new 2D-DIGE experiments using CoCl 2 , a well-known inducer of HIF-1 [24] , were carried out, using the human hepatoma cell line HepG2. These cells are sensitive to CoCl 2 and represent a well-established hypoxia model [8] .
It is known that CoCl 2 may also affect other cellular functions than the HIF-1 pathway [41] , but as we removed the results generated by this approach from the ones obtained with hypoxia, we did not increase the rate of false positives. However, it is possible that we excluded some hypoxia HIF-1 independent spots, due to a side effect of this molecule in a HIF-1 independent hypoxia-responsive pathway, thus decreasing slightly the rate of true positives. After comparison of the lists of the different proteins identified by mass spectrometry in both experiments, we decided to focus on some cytoskeleton proteins for two major reasons. First, they were already identified in the previous experiments using the two murine cell lines. Second, they may be involved in regulating the migration process, which is known to be enhanced under hypoxic conditions. Out of these proteins, only the abundance of DH IC-2 was increased at the protein level. As DH IC-2 is a component of cytoplasmic dynein, which is involved in directed cell movement [42] , we decided to focus on this protein. We first investigated if the increase in DH IC-2 protein level was dependent on a transcriptional effect. As DH IC-2 mRNA level was not elevated under hypoxia, we next investigated if the increase in DH IC-2 protein level may be the consequence of a stabilization of the protein. Blockage of protein synthesis by cycloheximide and follow-up of DH IC-2 protein level in a time course experiment revealed that this protein is less degraded under hypoxia. This result suggests that hypoxia-induced increase in DH IC-2 abundance is probably due to an accumulation of the protein rather than translational effect on the mRNA sequence. Under hypoxia, the overall protein synthesis is known to be slowed down following a limitation in ATP supply [43] . However, some mRNA (like VEGF) are still translated due to the presence of an IRES (internal ribosome entry site) sequence located in the 5′ untranslated region of the mRNA [44] . In silico analyses did not show such sequences in the DH IC-2 mRNA, leading to the conclusion that hypoxia-induced DH IC-2 overexpression is probably a consequence of the stabilization of this protein.
As post-translational modifications may increase the half-life of proteins, we next checked if DH IC-2 was altered by hypoxia. The results presented here clearly show that this protein is specifically modified under this condition. The shift observed by 2D-blot to a less acidic form of DH IC-2 suggests a loss of negative charges or a gain of positive ones. Different in silico analysis tools were used in order to define the potential modification involved in the DH IC-2 shift observed under hypoxia (data not shown). The NetPhos analysis pointed out putative phosphorylation sites and the immunoprecipitation studies showed that DH IC-2 is phosphorylated under normoxia and become de-phosphorylated under prolonged hypoxia (16 h). Calphostin C, a pan-inhibitor of PKC, also inhibited DH IC-2 phosphorylation while a decrease in PKC activity was observed after a prolonged incubation under hypoxia. We thus suggest that it is through PKC inhibition that hypoxia leads to the de-phosphorylation of DH IC-2 that we observed. HepG2 cells contain four PKC isoforms (α, δ, ɛ and ζ) [45] . Calphostin C inhibits all of them; further work is thus required to identify the actual isoenzyme responsible for DH IC-2 phosphorylation under normoxia. Several PCK isoenzymes have been found to be activated by short period of hypoxia in several cell types [46] [47] [48] . We postulate that prolonged hypoxia may lead to PKC deactivation through protein degradation as prolonged stimulation with PMA does [49] , thus resulting in a decreased PKC activity. This hypothesis needs to be confirmed.
As proteasome 26 s is one of the major systems involved in protein turn over [35] , we investigated if it could be implicated in DH IC-2 degradation. Proteasome activity was inhibited under normoxia by MG132 without any impact on DH IC-2 protein level suggesting that another pathway is in charge of its maintenance. Further work is needed to elucidate the mechanism involved in DH IC-2 degradation.
As we identified different cytoskeleton proteins, and as cytoplasmic dynein is involved in a variety of mechanisms like intracellular transport, mitosis, cell polarization and directed cell movement [28] , which could be of particular interest in cancer progression, we decided to evaluate the implication of dynein on cancer cell migration. First, hypoxia was shown to enhance in vitro HepG2 cells mobility, which is in accordance with different literature data generated in vitro or in vivo [9, 37] . Second, invalidation of DH IC-2 by siRNA increased HepG2 cell migration, to the same extent than hypoxia. The overall abundance of DH IC-2 is increased under hypoxia but the protein is no longer phosphorylated. In these conditions, HepG2 migration is increased. Two hypotheses can thus be put forward to explain these observations: (i) it is the abundance of DH IC-2 that regulates migration or (ii) it is the phosphorylation state of DH IC-2 that regulates migration. Since decreased DH IC-2 expression by siRNA enhanced cell migration, it is not its abundance that regulates migration. Indeed, if it would have been the case, an inhibition should have been observed. We thus proposed that it is the phosphorylated form of DH IC-2 that inhibits migration, while the unphosphorylated one favors migration: hypoxia, by inhibiting PKC activity and, hence, DH IC-2 phosphorylation would thus enhance cell migration. We have confirmed this hypothesis using calphostin C, a specific PKC inhibitor: under normoxia, PKC inhibition also resulted in an enhanced migration. In conclusion, hypoxia enhances migration by inhibiting DH IC-2 phosphorylation. This effect was purely due to motility since there was no effect on cell proliferation. This last result is surprising, as dynein is known to play a role in spindle assembly [50] . However, as DH IC-2 is a multi-subunit complex protein, it is possible that DH IC-2 is not necessary for spindle assembly or could be replaced by a redundant protein.
Taken together, these results suggest that DH IC-2 is modified under hypoxia. This modification could disrupt dynein complex and, in turn, lead to the accumulation of DH IC-2 into the cytoplasm. As intermediate chains are crucial for dynein assembly and to monitor partner interactions [51, 52] , we hypothesized that the exclusion of this modified form of DH IC-2 may change the set of the dynein interacting proteins or may disturb normal dynein functions, enhancing cell migration. These results are important for understanding cancer development as they highlight a new HIF-1 independent mechanism involved in metastasis. Fig. 10 . Effect of pan-PKC inhibition on HepG2 migration. HepG2 cells were plated in Boyden-like chambers for 24 h and incubated under normoxia, normoxia + calphostin C at 2 μM or hypoxia. (A) Cells that have migrated were stained with crystal violet. (B) The actual number of cells that have migrated has been counted on three fields for each membrane of each experiment. The results are expressed in induction fold for three independent experiments, as means ± SD (n = 3). ⁎⁎ or ⁎⁎⁎, p b 0.01 or p b 0.001 vs. normoxia. Fig. 11 . Effect of DH IC-2 invalidation on HepG2 proliferation. HepG2 cells were transfected with DH IC-2-directed siRNA for 24 h (NT = non-transfected, DF = Dharmafect 1 transfection agent, Scr = non-targeting siRNA, DH IC-2 = DH IC-2 siRNA smartpool). HepG2 cells were re-plated 24 h post-transfection and, 1 day later, incubated 24 h under normoxia and hypoxia. Optical density was measured at 570 nm. Results are presented as means ± SD (n = 4).
